MetaVia (MTVA) Return on Equity [ROE] (2016 - 2026)
MetaVia's Return on Equity [ROE] came in at -240.53% for Q2 2026, up 23.56 percentage points from -264.08% a year earlier.
Powered by 
Analysis
MetaVia (MTVA) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2025, MetaVia's Return on Equity [ROE] was -195.61%, up 28.57 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +108.86 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -224.18% in FY2024 (-159.29 pp), -64.89% in FY2023 (+11.96 pp), -76.85% in FY2022 (+63.37 pp) and -140.22% in FY2021 (+164.25 pp).
- The five-year range for quarterly Return on Equity [ROE] is -398.81% (Q1 2025) to -48.69% (Q2 2023).
- Year-over-year, Return on Equity [ROE] increased in two of the last seven quarters, with an average year-over-year change of -92.40 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2021 (a gain of 207.72 percentage points), and the weakest in Q1 2025 (a drop of 274.90 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | MetaVia | 10.13 Mn | -44.69 Mn | - | -240.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -240.53% |
| Dec 31, 2025 | -222.45% |
| Sep 30, 2025 | -203.27% |
| Jun 30, 2025 | -264.08% |
| Mar 31, 2025 | -398.81% |
| Dec 31, 2024 | -264.24% |
| Sep 30, 2024 | -173.90% |
| Jun 30, 2024 | -178.50% |
| Mar 31, 2024 | -123.91% |
| Dec 31, 2023 | -65.23% |
| Sep 30, 2023 | -50.62% |
| Jun 30, 2023 | -48.69% |
| Mar 31, 2023 | -64.82% |
| Dec 31, 2022 | -100.89% |
| Sep 30, 2022 | -187.79% |
| Jun 30, 2022 | -136.96% |
| Mar 31, 2022 | -111.86% |
| Dec 31, 2021 | -147.51% |
| Sep 30, 2021 | -387.31% |
| Jun 30, 2021 | -263.46% |
API Access
MetaVia Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MTVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MTVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MTVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();